TrialScientific reports2018

Metabolic Alterations Associated with Atorvastatin/Fenofibric Acid Combination in Patients with Atherogenic Dyslipidaemia: A Randomized Trial for Comparison with Escalated-Dose Atorvastatin.

Ji Soo Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.